Cholesterol meds may reduce liver cancer risk by 31%
A recent breakthrough study has uncovered a promising link between non-statin cholesterol-lowering medications and liver cancer prevention. Among the drugs examined, ezetimibe—commonly known by its
January 7, 2025
No Comments
